Charles Ryan, MD
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Charles Ryan, MD, is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of California San Francisco. His clinical research interests in prostate cancer include hormonal therapies, drug development strategies utilizing targeted therapies as well as angiogenesis inhibitors, chemotherapy, and tumor vaccines. Dr. Ryan also has experience in the study of genomic profiles of prostate tumors following androgen deprivation therapy. He has authored numerous publications in the area of prostate cancer and is an investigator on a number of active clinical trials both within the University of California San Francisco and through national cooperative groups. (This is me - Update Profile)
| 2003 - present | Assistant Professor of Medicine UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
|---|
GLG Study Groups with Charles Ryan, MD(?)
| Study Group Name | Members |
|---|---|
| Urologic Oncologists (US) | 147 |
| Oncologists (US) | 2254 |
GLG NewsSM
Analyses by Charles Ryan, MD(?)
Prior studies had suggested an improvement in survival when calcitriol was added to weekly docetaxel. The premature closure of this study ocurred due to an increased death rate in patients receiving the combination of weekly docetaxel compared to q 21 day docetaxel. Faulty trial design, and not necessarily...
GLG InstituteSM Seminars with Charles Ryan, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Charles Ryan, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms